Chi KN, Eisenhauer E, Fazli L, Jones EC, Powers J, Ayers D, Goldenberg SL, Gleave ME (2004) A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2′methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy....
Open simple prostatectomy (OSP) was another treatment of choice for large glands (≥80 g) [2]. However, during the last few decades, Holmium laser enucleation of the prostate (HoLEP) and robotic-assisted simple prostatectomy (RASP) have emerged as efficacious minimally invasive treatment options...